Shares of Seres Therapeutics Inc. MCRB, + 332.15% hit nearly fourfold (up 270%) on heavy volume in premarket trading Monday, after the microbiome therapy company reported faster results from a Phase 3 trial of its SER-109 for recurrent C. difficile infections (CDI), as an infection of the colon. Trading volume …
Read More »
The US-listed shares of Canopy Growth Corp. CGC, -5.08% WEED, -4.41% hit 6.8% in prime trade on Monday, after the Canada-based cannabis company reported a slower-than-expected fiscal loss from the first quarter, although revenue went up less than forecast. The net loss for the quarter to June 30 is limited …
Read More »
Shares of Foot Locker Inc. FL, + 1.92% rose 16% in premarket trading Monday, after the athletic shoe and retailer said it expects to report a surprising fiscal gain in the second quarter as the reopening of stores helped a surprising jump in sales. The company expects net earnings per …
Read More »
Roche Holding AG ROG, -0.27% said Friday that the Food and Drug Administration had approved Evrysdi, a treatment for spinal muscle atrophy in adults and most children. It is the second drug approved by the regulator to treat the rare disease. The therapy was developed by PTC Therapeutics Inc. PTCT, …
Read More »
Text size Michael M. Santiago / Getty Images The Nasdaq Composite hit 11,000 this past week – and all anyone wants to talk about is negative real rates. You see, it’s not good enough for the Nasdaq to win 2.5% for the week – and in the process break a …
Read More »